Literature DB >> 16792783

Successful treatment of vulval melanoma in situ with topical 5% imiquimod cream.

A A Lonsdale-Eccles, J M Morgan, S Nagarajan, D J Cruickshank.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16792783     DOI： 10.1111/j.1365-2133.2006.07297.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  3 in total

1.  Topical treatment of melanoma metastases with imiquimod, plus administration of a cancer vaccine, promotes immune signatures in the metastases.

Authors:  Ileana S Mauldin; Nolan A Wages; Anne M Stowman; Ena Wang; Walter C Olson; Donna H Deacon; Kelly T Smith; Nadedja Galeassi; Jessica E Teague; Mark E Smolkin; Kimberly A Chianese-Bullock; Rachael A Clark; Gina R Petroni; Francesco M Marincola; David W Mullins; Craig L Slingluff
Journal:  Cancer Immunol Immunother       Date:  2016-08-13       Impact factor: 6.968

2.  Topical treatment of recurrent vaginal melanoma in situ with imiquimod: A case report.

Authors:  Lauren S Prescott; Nicholas E Papadopoulos; Elizabeth D Euscher; Jack L Watkins; Kathleen M Schmeler
Journal:  Gynecol Oncol Case Rep       Date:  2012-04-30

3.  Imiquimod treatment of vulvar melanoma in situ invading the urethra.

Authors:  Esther Fuchs; Anisha Khanijow; Rochelle L Garcia; Barbara A Goff
Journal:  Gynecol Oncol Rep       Date:  2021-10-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.